Monitoring for DNA damage of humans occupationally exposed to methyl bromide. 2002

V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
Laboratory of Chemical Carcinogenesis, Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece. vpletsa@eie.gr

BACKGROUND Methyl bromide (MeBr) is a methylating agent, weak mutagen and possible animal carcinogen. A molecular epidemiological study to examine human exposure to, and consequent DNA damage by MeBr was conducted in an area where this agent is used extensively for soil sterilisation in greenhouses. METHODS During the first part of the study, blood samples were collected from 21 persons within 24 hours after use of MeBr for greenhouse sterilisation, as well as from 19 non-exposed subjects. Personal air sampling was also carried out, indicating mean air concentrations for different subjects in the range 11-78 mg/m3. In the second part of the study, an attempt was made to examine professional applicators of MeBr who suffered particularly high exposures (mean exposures, based on personal monitoring 23-165 mg/m3). The levels of N7-methylguanine and O6-methylguanine, two DNA adducts known to be induced by MeBr, were assessed in blood leukocyte DNA. RESULTS Concerning the first part, two subjects (one exposed and one control) were found to be positive for N7-methylguanine, while none of the blood samples analysed had detectable levels of O6-methylguanine. Among 6 such persons examined during the second part, 2 were found positive for N7-methylguanine while none was positive for O6-methylguanine. CONCLUSIONS Within the detection power of this limited study, no significant evidence of induction of DNA damage in blood leukocyte DNA by MeBr was found.

UI MeSH Term Description Entries
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D006115 Greece A country in southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey. The capital is Athens. Crete,Macedonia (Greece)
D006147 Guanine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006842 Hydrocarbons, Brominated Hydrocarbon compounds with one or more HYDROGEN atoms substituted with BROMINE. Brominated Hydrocarbons
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
November 2008, Journal of applied toxicology : JAT,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
September 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
January 1994, Journal of analytical toxicology,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
January 2006, Mutation research,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
September 2010, Toxicology letters,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
April 2006, Occupational and environmental medicine,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
September 2008, Environmental toxicology and pharmacology,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
January 1993, International archives of occupational and environmental health,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
November 2018, Mutation research,
V Pletsa, and M J S Steenwinkel, and M Stoikidou, and J H M van Delft, and R A Baan, and K Katsouyanni, and S A Kyrtopoulos
January 1987, The Journal of the Society of Occupational Medicine,
Copied contents to your clipboard!